Screening for cancer: Evaluating the evidence

American Family Physician

Volumn 63, Issue 3, 2001, Pages 513-522

  Gates, T J ^a  

^a LANCASTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COST; ETHICS; HUMAN; LUNG CANCER; MAMMOGRAPHY; MORBIDITY; PAPANICOLAOU TEST; PROSTATE CANCER; REVIEW; SIGMOIDOSCOPY; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TOBACCO; UTERINE CERVIX CANCER;

BIAS (EPIDEMIOLOGY); ETHICS, MEDICAL; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; NEOPLASMS; PROGRAM EVALUATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0035251652     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Screening for early and asymptomatic conditions
2. Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs
3. Early diagnosis
4. Medical screening and the value of early detection. When unwarranted faith leads to unethical recommendations
5. Ethical considerations in the provision of controversial screening tests
6. Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits
7. Gains in life expectancy from medical interventions - Standardizing data on outcomes
8. Number needed to screen: Development of a statistic for disease screening
9. The number needed to treat: A clinically useful measure of treatment effect
10. A comprehensive program for cervical cancer detection and management
11. Determinants of cancer screening frequency: The example of screening for cervical cancer
12. Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate
13. Early Lung Cancer Action Project: Overall design and findings from baseline screening
14. Reducing mortality from colorectal cancer by screening for fecal occult blood
15. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
16. Randomised study of screening for colorectal cancer with faecal-occult-blood test
17. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
18. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
19. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
20. Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved
21. Efficacy of screening mammography. A meta-analysis
22. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age
23. Whither scientific deliberation in health policy recommendations? Alice in the wonderland of breast-cancer screening
24. Ten-year risk of false-positive screening mammograms and clinical breast examinations
25. Is screening for breast cancer with mammography justifiable?
26. Prostate cancer screening: More harm than good?
27. Changes in prostate cancer incidence and treatment in USA
28. Cancer incidence and mortality, 1973-1995: A report card for the U.S.
29. Prostate carcinoma incidence and patient mortality: The effects of screening and early detection